Our Heritage

Adcock Ingram has a proud heritage which spans more than 120 years. The business started as a small Krugersdorp pharmacy. Its founders branched out into new product development, manufacturing, distribution, and sales and marketing.

Adcock Ingram was first listed on the Johannesburg Stock Exchange (JSE) in 1950 and enjoyed blue chip status. In 2000 Tiger Brands (then the majority shareholder) acquired the minority shares, and Adcock Ingram was delisted from the JSE and operated as a whollyowned subsidiary of Tiger Brands. On 25 August 2008, Adcock Ingram was unbundled from Tiger Brands and relisted on the JSE

Take a journey with us and explore our rich history to see how we've continually evolved to keep up with the expectations and needs of all our stakeholders.




  • 1890
    • E.J. Adcock Pharmacy opened its doors in Krugersdorp.
  • 1940
    • The first pharmaceutical manufacturing facility was commissioned in Aeroton.
  • 1948
    • A license agreement with Baxter Healthcare, USA for Hospital products was signed.
  • 1950
    • Adcock Ingram was listed on the JSE.
  • 1987
    • Myprodol, the locally developed and pantented analgesic/anti-inflammatory was launched.
  • 1996
    • The merger between Adcock Ingram and Premier Pharmaceuticals made Adcock the No.1 OTC company in SA.
  • 1999
    • Construction of a new R&D centre.
  • 2000
    • Adcock Ingram de-listed from the JSE and became a wholly owned subsidiary of Tiger Brands.
  • 2001
    • Acquisition of Steri-Lab, which provided the base from which to develop a medical diagnostics business known as Adcock Ingram Scientific.
  • 2003
    • Acquisition of Abbott Consumer Business.
    • Acquisition of the Parke Med generics business from Pfizer laboratories extended Adcock Ingram’s range of generic products.
  • 2005
    • Adcock Ingram launches its range of generic ARV products.
  • 2007
    • Adcock‘s R&D facility achieved WHO accreditation.
    • Joint venture with an Indian Partner (Medreich Limited) formation of Adcock Ingram India.
  • 2008
    • Partnership with Baxter International extended for 15 years.
    • Adcock Ingram takes occupation of its brand new, state of the art Distribution Centre in Midrand, South Africa.
    • Adcock Ingram unbundled from Tiger Brands Limited and independently listed on the JSE in August 2008.
  • 2009
    • Kenya operations launched.
    • SA acquisitions – Tender Loving Care (Pty) Ltd; Batswadi Biotech (Pty) Ltd and Unique Formulations.
    • Broad Based BEE transaction announced.
  • 2010
    • Acquired 62,2% of Ayrton Drug Manufacturing Limited in Ghana.
    • Significant MNC contracts signed – MSD Lilly and Novartis.
    • New Durban Distribution Centre opened.
  • 2011
    • SA acquisition - Nutrilida.
  • 2012
    • Acquired remaining 50% of Datlabs in Zimbabwe.
    • Opened High Volume Liquids Plant in Clayville.
  • 2013
    • Acquired Cosme Farme Ltd in India.
    • Wadeville facility obtained FDA acceptance.
prev next